subject: Pharmaceutical Engineering and Biopharmaceutical Plants making Huge Success [print this page] Pharmaceutical Engineering and Biopharmaceutical Plants making Huge Success
Biopharmaceuticals is a related branch of Pharmaceutical engineering. Biopharmaceutical plants use the concepts of biotechnology to develop medicines. Some of the living organisms especially belonging to plant origin have great healing capacities. Biopharmaceutical plants use these plants and other botanical sources to develop medicines.
There is a huge demand of safe and recombinant proteins. These proteins are highly potential and can cure a number of diseases. Insulin, growth hormones and red blood cell stimulating agents can cure many diseases such as multiple sclerosis, arthritis and other orphan diseases. Thus the main aim of pharmaceutical engineering is to produce more and more recombinant proteins to develop solutions for a number of diseases.
At present, there are about 80 biopharmaceutical plants in the market and around 500 are under their development stages and yet to be launched. There are some recombinant proteins such as recombinant antibodies (rAbs) and monoclonal antibodies (Mabs) which are highly in demand as they are highly potential and can cure various diseases. Biopharmaceutical plants accounts for the 40% of the total production of these highly potential recombinant proteins. It is also working in other key areas such as transplant, auto-immunity and other cardiovascular disorders.
With the advent of pathogenesis, pharmaceutical engineering has made a huge success. This technique can potentially solve many diseases and can increase the life span of the sufferers. Biotechnology has given many solutions to medical world. The major challenge faced by these plants is that it needs a huge investment cost. Hence, pharmaceutical manufacturing industries are trying hard to make cost-effective medicines so that it can be affordable by everyone.
